Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines

OBJECTIVES: To determine the seroconversion (SC) rate after CoronaVac and BNT162b2 vaccines in adults with inflammatory rheumatic disease (IRD). METHODS: Patients who were followed up with IRD and who received two doses of either CoronaVac or BNT162b2 vaccines were included in this prospective obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Batıbay, Sevilay, Ulucaköy, Rezan Koçak, Günendi, Zafer, Fidan, Işıl, Bozdayı, Gülendam, Göğüş, Feride Nur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593974/
https://www.ncbi.nlm.nih.gov/pubmed/36282425
http://dx.doi.org/10.1007/s10787-022-01089-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593974/
https://www.ncbi.nlm.nih.gov/pubmed/36282425
http://dx.doi.org/10.1007/s10787-022-01089-6

Ejemplares similares